文献速递肝病消化道肿瘤与早癌

雄激素受体在乙肝病毒整合或启动子点突变后增强肝端粒酶逆转录酶基因转录

Androgen Receptor Enhances Hepatic Telomerase Reverse Transcriptase Gene Transcription After Hepatitis B Virus Integration or Point Mutation in Promoter Region.
PubMed 文献 · Hepatology · 2019-01-16

该研究分析101例HBV相关肝细胞癌病例,发现HBV整合与TERT启动子-124G>A突变互斥且男性更常见;报告基因实验显示雄激素受体通过HBV整合或TERT启动子突变增强TERT转录,且依赖HNF4α或GABPA,提示端粒酶和AR可能为干预靶点。

要点

  • HBV整合与TERT启动子-124G>A突变在HBV相关肝细胞癌中互斥出现,且男性频率高于女性。
  • 雄激素受体经HBV整合或TERT启动子突变增强TERT转录,分别依赖HNF4α或GABPA。
  • 作者认为端粒酶和雄激素受体可能是干预HBV相关肝细胞癌的靶点。

核心结论

  • 雄激素受体通过整合的HBV和TERT启动子点突变上调TERT,被确定为HBV相关肝细胞癌男性优势的机制;端粒酶和AR因此可能是干预肝细胞癌的靶点。

研究设计与样本

  • 使用捕获-下一代测序平台分析101例HBV相关肝细胞癌病例的HBV整合位点及TERT启动子和TP53编码区常见突变。
  • 采用报告基因实验研究性激素通路对携带上述两种遗传改变的TERT表达的影响。

主要发现

  • HBV整合在男性肝细胞癌患者中为22/58例、女性为6/36例(P=0.0285)。
  • TERT启动子-124G>A突变在男性肝细胞癌患者中为17/62例、女性为3/39例(P=0.0201)。
  • HBV整合与-124G>A突变合并出现于男性39/62例、女性9/39例(P<0.0001)。
  • HBV整合与TERT启动子-124G>A突变以互斥方式发生。
  • TERT启动子中的HBV整合使TERT转录对性激素产生反应,雄激素受体增强而雌激素受体抑制,两者均依赖肝细胞核因子4α。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The gender disparity of hepatocellular carcinoma (HCC) is most striking in hepatitis B virus (HBV)-related cases. The majority of such HCC cases contain integrated HBV, and some hotspot integrations, such as those in the telomerase reverse transcriptase gene (TERT) promoter, activate gene expression to drive carcinogenesis. As the HBV genome contains both androgen-responsive and estrogen-responsive motifs, we hypothesized that the integrated HBV DNA renders a similar regulation for downstream gene expression and thus contributes to male susceptibility to HCC. To test this hypothesis, the HBV integration sites and the common mutations in the TERT promoter and tumor protein P53 (TP53) coding region were analyzed in 101 HBV-related HCC cases using a capture-next-generation sequencing platform. The results showed that both HBV integration and -124G>A mutation in the TERT promoter region, occurring in a mutually exclusive manner, were more frequent in male than in female patients with HCC (integration: 22/58 male patients with HCC, 6/36 female patients with HCC, P = 0.0285; -124G>A: 17/62 male patients with HCC, 3/39 female patients with HCC, P = 0.0201; in combination, 39/62 male patients with HCC, 9/39 female patients with HCC, P < 0.0001). The effects of sex hormone pathways on the expression of TERT with both genetic changes were investigated using a reporter assay. HBV integration in the TERT promoter rendered the TERT transcription responsive to sex hormones, with enhancement by androgen receptor (AR) but suppression by estrogen receptor, both of which were dependent on hepatocyte nuclear factor 4 alpha. Besides, AR also increased TERT expression by targeting TERT promoter mutations in a GA binding protein transcription factor subunit alpha-dependent manner. Conclusion: TERT elevation by AR through integrated HBV and point mutation at the TERT promoter region was identified as a mechanism for the male dominance of HBV-related HCCs; telomerase and AR thus may be targets for intervention of HCC.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Li CL, Li CY, Lin YY, et al. Androgen Receptor Enhances Hepatic Telomerase Reverse Transcriptase Gene Transcription After Hepatitis B Virus Integration or Point Mutation in Promoter Region. Hepatology. 2019. PMID: 30070724. doi:10.1002/hep.30201

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。